XML 25 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Oct. 31, 2018
Apr. 30, 2018
Current Assets:    
Cash and cash equivalents $ 9,477 $ 9,716
Restricted cash 679 1,242
Receivables, less allowance; $372; $384, on each respective date 29,785 32,660
Inventories 17,097 17,662
Prepaid expenses and other current assets 3,251 2,224
Total Current Assets 60,289 63,504
Property, plant and equipment, at cost 56,120 54,648
Accumulated depreciation (41,252) (39,987)
Net Property, Plant and Equipment 14,868 14,661
Deferred income taxes 1,888 2,031
Other 3,551 4,162
Total Other Assets 5,439 6,193
Total Assets 80,596 84,358
Current Liabilities:    
Short-term borrowings and interest rate swaps 4,658 3,885
Current portion of long-term debt and lease obligations 1,184 1,167
Accounts payable 10,726 14,754
Employee compensation and amounts withheld 3,162 3,810
Deferred revenue 1,563 1,884
Other accrued expenses 2,743 2,062
Total Current Liabilities 24,036 27,562
Long-term debt 822 1,264
Accrued pension and deferred compensation costs 6,016 7,465
Income taxes payable 339 546
Total Liabilities 31,213 36,837
Commitments and Contingencies
Stockholders' Equity:    
Common Stock, $2.50 par value, Authorized - 5,000 shares; Issued - 2,747 shares; 2,736 shares; - Outstanding - 2,744 shares; 2,733 shares, on each respective date 6,869 6,841
Additional paid-in-capital 3,224 3,006
Retained earnings 45,888 43,165
Accumulated other comprehensive loss (7,008) (5,900)
Common stock in treasury, at cost, 3 shares, on each date (53) (53)
Total Kewaunee Scientific Corporation Stockholders' Equity 48,920 47,059
Noncontrolling interest 463 462
Total Stockholders' Equity 49,383 47,521
Total Liabilities and Stockholders' Equity $ 80,596 $ 84,358